According to Dechra Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $94.14 M. In 2022 the company made an earning of $94.14 M a decrease over its 2021 earnings that were of $0.10 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | $94.14 M | -8.1% |
2021 | $0.10 B | 103.45% |
2020 | $50.35 M | 42.67% |
2019 | $35.29 M | -7.54% |
2018 | $38.17 M | 2.71% |
2017 | $37.16 M | 89.7% |
2016 | $19.59 M | -51.75% |
2015 | $40.59 M | 11.15% |
2014 | $36.52 M | 92.51% |
2013 | $18.97 M | -28.07% |
2012 | $26.37 M | -11.38% |
2011 | $29.76 M | 12.32% |
2010 | $26.49 M | -0.07% |
2009 | $26.51 M | 13.67% |
2008 | $23.32 M | -8.38% |
2007 | $25.46 M | 24.69% |
2006 | $20.42 M | 17.58% |
2005 | $17.36 M | 29.48% |
2004 | $13.41 M | 37.29% |
2003 | $9.77 M | 7.95% |
2002 | $9.05 M | 53.14% |
2001 | $5.9 M |